MARSHALL WACE, LLP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$461,000
-88.1%
293,934
-82.3%
0.00%
-85.7%
Q1 2022$3,864,000
+653.2%
1,658,516
+3639.4%
0.01%0.0%
Q1 2015$513,00044,3520.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders